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Abstract
Background: Sickle cell anemia is caused by a single type of mutation, a homozygous ART substitution in the ß globin
gene. Clinical severity is diverse, partially due to additional, disease-modifying genetic factors. We are studying one such
modifier locus, HMIP (HBS1L-MYB intergenic polymorphism, chromosome 6q23.3). Working with a genetically admixed
patient population, we have encountered the necessity to generate haplotype signatures of genetic markers to label
genomic fragments with distinct genealogical origin at this locus. With the goal to generate haplotype signatures from
patients experimentally, we have investigated the suitability of an existing nanofluidic assay platform to perform phase
alignment with single-nucleotide polymorphism alleles.
Methodology/Principal Findings: Patient DNA samples were loaded onto Fluidigm Digital Arrays and individual DNA
molecules were assayed with allele-specific probes for SNP markers. Here we present data showing the utility of the
nanofluidic approach, yielding haplotype data identical to those obtained with a family-based method. We then determined
haplotype composition in a group of patients with sickle cell disease, including in those where a mathematical inference
approach gave ambiguous or misleading results. Experimental phasing of genotypes across 3.8 kb for rs9399137,
rs9402685, and rs11759553 created unequivocal haplotype signatures for each of the patients. In 68 patients, we found 8
copies of a haplotype signature (‘C-C-T’), which is known to be prevalent in Europeans but to be absent in West African
populations. We have confirmed the identity of our phased allele pairs by single-molecule sequencing and have
demonstrated, in principle, that three-allele phasing (using three colors) is a potential extension to this method.
Conclusions/Significance: Phased haplotypes yield more information than the individual marker genotypes. Procedures
such as the one described here would therefore benefit genetic mapping and functional studies as well as diagnostic
procedures where the identity or parental origin of short genetic fragments is of importance.
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Introduction
Sickle cell anemia is a devastating autosomal-recessive genetic
condition [MIM 603903], caused by a mutation in the gene (HBB,
on chromosome 11p15.4) coding the beta hemoglobin polypep-
tide, which provides two of the four subunits of adult hemoglobin.
While the homozygous mutant genotype is the same in all patients,
other genetic factors contribute to marked clinical variability.
Several modifier loci act through promoting the persistence of fetal
hemoglobin (HbF) into adulthood, which can stand in for the
mutated adult hemoglobin and lead to a milder disease phenotype.
One such locus is the HBS1L-MYB intergenic polymorphism,
block 2 (HMIP-2) [1] on chromosome 6q23.3.
Our patients are of Caribbean and West African origin, but the
presence of European genetic admixture provides for additional
genetic complexity. To address the confounding influence of non-
African alleles in our patients, we are conducting a survey of
haplotypes at HMIP locus. Haplotypes are arrays of marker alleles
on each of the two sister chromosomes at a given genetic locus.
Traditionally they are detected through family studies or by
mathematically inferring them from marker genotypes. Since
family members for our patients are not available to study, and
mathematical inference is occasionally not conclusive, it was our
goal to devise a novel, direct lab-based method to align marker
alleles into haplotypes, using a nanofluidic approach.
It has been shown previously that experimental haplotyping in
individual samples can be achieved [2,3,4,5,6,7,8], but it is the
advent of high-throughput ‘digital’ technologies [9,10,11,12,13,14]
that probe individual sample DNA molecules, which offers
efficient approaches to phase-defined genotyping that would be
amenable to the large-scale studies of complex genetic conditions.
We have used one such newly-established high-throughput
sequence detection platform using ‘digital’ assaying, the Fluidigm
Digital Array
TM (Figure 1). The Digital Array platform uses
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level where individual target molecules are isolated and can be
individually probed. Thus, target strands derived from maternal or
paternal chromosomes can be genotyped separately for neighbor-
ing SNPs (single-nucleotide polymorphisms), and phase/haplotype
information for these SNPs can be directly derived. We selected
three SNPs within HMIP-2, including the tag SNP for the locus,
rs9399137, as well as two neighboring SNPs, rs9402685 and
rs11759553 (Figure 2). Separate phasing experiments were
conducted in double-heterozygous patients for the marker pairing
rs9399137 and rs9402685, 670 bp apart, and the pairing
rs9402685 and rs11759553, 2,608 bp apart.
Here, we first describe a procedure to use Fluidigm Digital Arrays
for the rapid generation of phase information from genotypes, we then
show that haplotypes generated in such way are accurate, i.e. identical
to those generated by phase assignment within a family and finally, we
investigate a group of sickle cell patients to identify distinct haplotypes
in each individual through three-SNP haplotype signatures.
Methods
Subjects
Four members (Figure 3) of a large family, which originates
from North West India and which segregates b thalassaemia and
heterocellular hereditary persistence of fetal hemoglobin, have
previously been studied to investigate the influence of the HMIP
loci [15].
68 patients with sickle cell anemia (HbS homozygous) are part of a
study to investigate the effects of HMIP-2 [16] and other loci on fetal
hemoglobin levels and disease severity. Patients had complete
genotype data for SNPs rs9399137, rs9402685, and rs11759553.
Patients are of West African and Afro-Caribbean ancestry with
European genetic admixture. SNPs genotyped in these patients show
distinct linkage disequilibrium (LD) relationships in European and
African descended populations [16]. In Europeans, LD is very tight,
with D9=1/r
2=1 for rs9399137–rs9402685 and D9=1/r
2=0.88
for rs9402685–rs11759553. In an admixed Caribbean population,
LD was found to be weaker, with D9=1/r
2=0.11 for the first pairing
and D9=0.49/r
2=0.16 for the second [16]. Phase information for
theses SNPs is intended to ultimately aid fine-mapping of this region
in patients with sickle cell disease.
The software package PHASE v2.1.1 [17] was used to
mathematically infer haplotypes from genotypes alone, prior to
obtaining experimental phase information.
Ethical approval has been given for our ongoing studies to
investigate HMIP-2 and other disease modifier loci (King’s
College Hospital Local Ethics Research Committee, LREC 01-
083). Written informed consent was given by all subjects.
Experimental haplotyping procedure
The Fluidigm Digital Array [18,19,20,21,22] is a nanofluidic
biochip where digital PCR reactions can be performed with
isolated individual DNA template molecules. It is conventionally
used for absolute quantitation (‘‘molecule counting’’) of genomic
DNA and cDNA, rare mutation detection [18], and determination
of copy number variation [20,21] (CNV). Utilizing soft lithography
and silicone rubber to create nanoscale valves and pumps, the
digital array delivers mixtures of sample and PCR reagents into
individual reaction chambers. We have utilized both 1
st-genera-
tion digital arrays [18,19,20,21,22], which partition 12 samples
into 765 reaction chambers each, as well as a 2
nd generation digital
arrays, which are capable of dividing up to 48 different samples
into 770 reaction chambers each. We have previously [20] shown
that one can use the digital array for multiplex PCR, using
TaqMan assays with different fluorophores, thereby identifying
multiple loci in a single reaction chamber.
A PCR/probe reaction mix (for two neighboring SNPs)
contained 16 TaqMan gene expression master mix (Applied
Biosystems, Foster City, CA), 900 nM each of the four primers,
200 nM each of the two probes (FAM and VIC-labeled,
respectively, detecting one allele each of both SNPs), and subject
DNA at appropriate concentration so that there will be 70–100
genomic DNA molecules in each of the panels.
Primers and allele probes used here were designed at the Centre
National de Ge ´notypage, Evry, France, and are the same as were
used in conventional TaqMan genotyping assays (Applied Biosys-
tems, Foster City, CA) in our previous studies [1] (for all
oligonucleotide sequences, see Methods S1). All primers were
supplied by Integrated DNA Technologies (Coralville, IA) and
TaqMan MGB (minor-groove binding) probes containing fluor-
ophores and non-fluorescent quenchers were from Applied
Biosystems (Foster City, CA). After sample loading, the digital array
was thermocycled on the BioMark system (http://www.fluidigm.
com/products/biomark-main.html), which included a 95uC, 10-
minute hot start followed by 50 cycles of two-step PCR: 15 seconds
at 95uC for denaturing and 1 minute at 60uC for annealing and
extension. FAM and VIC signals were recorded at the end of each
PCR cycle and the Digital PCR Analysis software (Fluidigm, South
San Francisco, CA) was used to process the data after the reaction.
Chambers that yielded signals for either probe alone or for both
probes were detected and counted. Co-localization was calculated
as follows: in each panel there are m FAM-positive chambers and n
VIC-positive chambers. m and n are close but not necessarily the
same due to DNA breakage and random sampling. The number of
chambers positive for both FAM and VIC is p. ‘‘Co-localization
index’’ would be expressed as p divided by the smaller of m or n.
Single-molecule sequencing
This method was used as an additional check on our digital-
array haplotype alignments.
Figure 1. 48-panel nanofluidic array. 2
nd generation Fluidigm
Digital Arrays
TM provide for 48 independent haplotyping experiments
with each 2-h run of the platform. Loading wells for the 48 experiments
are at the top end of the array. Each well leads to a panel of 770
reaction chambers, in which individual target molecules can be isolated
and assayed.
doi:10.1371/journal.pone.0013004.g001
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from family member FM01 were diluted to single molecule level and
amplified across rs9399137 and rs9402685 on an ABI 7900 real time
PCR instrument (Applied Biosystems, Foster City, CA). Forty 10-ml
reactions were performed for each sample, containing 16TaqMan
gene expression master mix (Applied Biosystems, Foster City, CA),
900 nM each of the primers C6-F and C6-R, 0.26 Sybr Green
(Invitrogen, Carlsbad, CA) and DNA molecules. Cycles were 95uC,
10 minutes and 50 cycles of 15 seconds at 95uCa n d1m i n u t ea t6 0 uC.
Efficiency was monitored by a melting curve step. 85 PCR products
were sequenced by Sequetech (Mountain View, CA) with both
primers, C6-F and C6-R. 74 of these PCR were apparently from single
molecules because they showed unequivocal sequencing traces and
singular base calls in both SNP positions.
Results
A procedure for rapid haplotyping with digital arrays
DNA samples are chosen form individuals that are double-
heterozygous for the SNP pair to be haplotyped. Genomic DNA is
mixed with PCR reagents for both SNPs, including primers and
probes, and loaded onto ‘panels’ of reaction chambers, where it is
partitioned so that individual target strands can be assayed in
TaqMan reactions with one probe per SNP.
As an example, the dispersion of 459 pg of sample DNA
(containing 70 copies of a SNP allele from a heterozygous genotype)
across the 765 chambers of a panel results in most chambers being
unoccupied with target DNA sequence, but those 70 copies present
are mostly isolated in individual reaction chambers. Each occupied
chamber generates a fluorescent signal for the allelic probe used in
the PCR reaction. A second allele, belonging to a neighboring SNP
and assayed with a differently-labeled probe, is present in the same
set of chambers only if it is located on the same DNA double-strand
molecule, i.e. ‘in phase’ with the first allele (Figure 4a). If the second
allele sits on the other sister chromosome, i.e. is ‘in repulsion’ to the
first allele, an entirely independent set of 70 chambers generates a
different fluorescent signal for this probe (Figure 4b). Under this
second scenario, the two probes may ‘co-localize’ only stochastical-
ly, i.e. in a small number of chambers (for this example 76560.09
2,
i.e. 6 to 7 in each panel).
Figure 2. The HMIP-2 region on chromosome 6q. The locus consists of array of intergenic SNPs on human chromosome 6q23.3, termed HMIP-2
(HBS1L-MYB intergenic polymorphism, block 2). In Caucasian populations, SNP alleles are locked into two frequent haplotypes, which underlie
variability in the level of residual fetal hemoglobin (HbF) in adult red blood cells. The causative sequence variant contained here is so far unknown.
Haplotype 2, identified here by the short haplotype signature ‘C - C - T’, promotes HbF persistence [1] and can alleviate sickle cell disease and b
thalassaemia. In Figure 3, this haplotype is represented by ‘C - C’. To experimentally detect these haplotypes in unrelated individuals, phasing
experiments have to bridge a distance of 670 bp between rs9399137 and rs9402685, and a distance of 2,608 bp between rs9402685 and rs11759553.
rs35959442 was previously cited as rs52090909 and rs9494142 as rs11154792. Locations and distances are from UCSC Genome Browser, v. March
2006, the ideogram, with permission, from Michelle M Le Beau, Chicago.
doi:10.1371/journal.pone.0013004.g002
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are analyzed using the Digital PCR Analysis software (Fluidigm,
South San Francisco, CA), which detects and counts co-localizing
and isolated probe signals. Results are scored as ‘in phase’
(predominant co-localization) or ‘in repulsion’ (predominant
isolation of signals).
While the actual co-localization data were subject to some
experimental variability, they grouped, across all our results,
into two completely separated clusters (Figure 5, Table 1,
Tables S1 and S2). Co-localization indices between 50% and
100% were seen for alleles in phase, and ,20% for alleles in
repulsion.
The presence of 70 to 100 targets per panel appeared to be the
optimum. Nevertheless, unequivocal phase data were obtained
from as little as about 30 and as many as about 200 target
molecules per probe present (Table 1, Tables S1 and S2).
The procedure is relatively quick, taking about 2.5 hours from
DNA sample to phase result. The number of panels on each chip
(array) determines the throughput. Up to 12 samples (alternatively,
twelve different SNP pairs) can be haplotyped in one experiment
Figure 3. Family-based haplotyping in individuals FM 1, 2, 3 and 4. All individuals are part of the same extended family, and the complete
haplotypes (not shown) contain .80 SNP markers and microsatellites. Boxes illustrate how phase is derived initially from homozygous individuals,
and then propagated through the pedigree sketch. As typical for European and South Asian Caucasian individuals, only two of the four possible
haplotypes occur. In this family, haplotype ‘C – C’ is associated with raised HbF and milder thalassemia [1,15].
doi:10.1371/journal.pone.0013004.g003
Figure 4. Digital-array haplotyping of SNP pair rs9399137–rs9402685. Shown is the graphical representation of the signal distribution on
four panels of a digital array by the Digital PCR Analysis software. (a) Two samples phased using probes for rs9399137-T-FAM with rs9402685-T-VIC,
resulting in a co-localization index of 95% and 98%, (b) the same two samples phased with rs9399137-T-FAM and rs9402685-C-VIC, resulting in a co-
localization index of 19% and 15%.
doi:10.1371/journal.pone.0013004.g004
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larger second-generation arrays (Figure 1).
Confirmation of phase data in a family study
We experimentally haplotyped a pair of SNPs (rs9399137 and
rs9402685) in four double-heterozygous individuals, where phase
information had previously been obtained through family
relationships (Figure 3). Among the test individuals, as it is typical
for this locus in individuals of European and South Asian
Caucasian origin, only two of the four possible haplotypes exist,
i.e. T (for rs9399137)–T (for rs9402685), and C (rs9399137)–C
(rs9402685). Therefore, being heterozygous, all four individuals
have the same haplotype situation for this SNP pair, T - T on one
chromosome, and C - C on the other (Figure 3).
Digital array haplotyping was performed four times for each
person (Table 1), using two different probe combinations: allele ‘T’
for rs9399137 was paired either with allele ‘T’ or with allele ‘C’ for
rs9402685. Both test combinations yielded consistent results
Figure 5. Co-localization index results for both primer pairs tested. This graph represents a summary of all digital-array haplotyping
experiments carried out. Notable is the very distinct clustering for alleles in phase and those in repulsion.
doi:10.1371/journal.pone.0013004.g005
Table 1. Digital-array haplotyping: Test for accuracy of the approach in a family study.
FAM allele
FAM
targets
detected VIC allele
VIC
targets
detected
Chambers
with both
signals
Chambers
with either
signal
Minimum
of the two
(FAM or VIC) % co-localization
Haplotypes
derived
FM1 rs9399137-T 120 rs9402685-T 173 112 181 120 93% (in phase) T-T and C-C
rs9399137-T 124 rs9402685-T 163 111 176 124 90% (in phase) T-T and C-C
rs9399137-T 147 rs9402685-C 149 23 273 147 16% (in repulsion) T-T and C-C
rs9399137-T 144 rs9402685-C 133 13 264 133 10% (in repulsion) T-T and C-C
FM2 rs9399137-T 98 rs9402685-T 103 50 151 98 51% (in phase) T-T and C-C
rs9399137-T 113 rs9402685-T 124 81 156 113 72% (in phase) T-T and C-C
rs9399137-T 88 rs9402685-C 108 9 187 88 10% (in repulsion) T-T and C-C
rs9399137-T 99 rs9402685-C 91 6 184 91 7% (in repulsion) T-T and C-C
FM3 rs9399137-T 193 rs9402685-T 211 185 219 193 96% (in phase) T-T and C-C
rs9399137-T 183 rs9402685-T 193 173 203 183 95% (in phase) T-T and C-C
rs9399137-T 176 rs9402685-C 125 6 295 125 5% (in repulsion) T-T and C-C
rs9399137-T 179 rs9402685-C 147 10 316 147 7% (in repulsion) T-T and C-C
FM4 rs9399137-T 103 rs9402685-T 106 99 110 103 96% (in phase) T-T and C-C
rs9399137-T 128 rs9402685-T 125 118 135 125 94% (in phase) T-T and C-C
rs9399137-T 121 rs9402685-C 109 10 220 109 9% (in repulsion) T-T and C-C
rs9399137-T 117 rs9402685-C 104 7 214 104 7% (in repulsion) T-T and C-C
Individuals FM1, 2, 3, and 4 were known to be double-heterozygous for the SNP marker pair rs9399137–rs9402685, and phase between the alleles had previously been
determined through family relationships (Figure 3). Digital-array haplotyping was carried out in duplicate, with two different probe (i.e., allele) combinations each.
All tests arrived at the correct haplotype combination for all for subjects: ‘T-T’ on one chromosome, and ‘C-C’ on its sister chromosome.
doi:10.1371/journal.pone.0013004.t001
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repulsion’ for the second combination, Table 1) and all
experiments yielded the correct haplotype make-up, identical to
that found through the family study (Figure 3).
Digital-array haplotyping of patients with sickle cell
disease
We experimentally generated phase information in those 16 of
the 68 patients in the study, where heterozygosity of two or three
genotypes prevented the unambiguous reading of haplotypes
directly from genotype data. For rs9399137–rs9402685, digital-
array phasing was performed in seven patients, for rs9402685–
rs11759553 in thirteen patients. All experiments were conducted
at least in duplicate, which always included a reverse-phase
experiment, where two alleles were paired in an alternative
combination. The patient results are summarized in Table 2.
Individual experiments are shown in Tables S1 and S2 and are
also included in Figure 5.
The haplotype combinations detected, including those for the
reverse-phase experiment, were the same for each patient. As an
additional check on the accuracy of the haplotypes detected in the
patients, we performed single-molecule sequencing on all seven
patient samples phased for the SNP pair rs9399137–rs9402685,
along with one of the family members (FM01). Phases obtained for
these two markers by sequencing were identical to those from
digital arrays (Table 1 and Table S1).
Haplotype make-up of the patient population
Digital-array haplotyping resolved phase in all 16 patients with a
previously unknown haplotype make-up. This now provided all
information necessary to derive three-SNP haplotype signatures
(rs9399137–rs9402685–rs11759553) at the HMIP-2 locus for all 68
patients (Table 3). Haplotypes directly observed in an individual
occasionally differed from those identified as the most likely ones by the
mathematical algorithm implemented in PHASE 2.1.1 [17] (Table 3).
The spectrum of haplotypes occurring in the patient population
is much more diverse than that previously found in Europeans.
Haplotype 1 (T-T-A) is similarly prevalent in both populations.
Alleles forming this haplotype are usually associated with low trait
(HbF) values [1,16]. In contrast, the other haplotype common in
Europeans, haplotype 8 (C-C-T), which contains the high-trait ‘C’
allele for rs9399137, is relatively rare in the African-descended
patients, and seems often admixture-derived (data not shown).
Instead, in the patients the ‘intermediate’ haplotypes 2, 3, and 4
are prevalent, and it is these which would be expected to be
informative for fine-mapping and functional studies.
Three-color haplotyping
The haplotyping strategy investigated in this paper is based on
establishing phase between two neighboring SNP markers with
heterozygous genotypes. Haplotypes would then be expanded by
‘walking’ along the chromosome, establishing phase with the next
heterozygous marker and the next after that, while phase with
homozygous markers in between is dictated by the genotype
already.
We have briefly explored an alternative approach, i.e. to phase
three alleles at once, from three markers, using three different
fluorophores. For this, the approach was identical to digital-array
haplotyping described above for the pair rs9399137–rs9402685,
but an additional primer pair and one ROX-labeled allele probe
(Methods S1) for rs6930223 was added. This marker is 4.5 kb
distal to rs9402685 and 5.2 kb distal to rs9399137. Initial results
indicate that obtained co-localization scores seem to be unaffected
by the presence of three colors and only marginally affected by the
somewhat greater distance between markers. They were between
0 and 11.3% for alleles in repulsion, and between 54.5% and
95.9% for alleles in phase (individual data not shown).
Discussion
We have demonstrated a simple and fast method to experi-
mentally obtain SNP haplotype data using nanofluidic chips that
allow the isolation and assaying of individual human genomic
DNA template molecules. Haplotyping with such ‘Fluidigm
Digital Arrays’, we investigated the HMIP-2 disease modifier
locus in patients with sickle cell disease.
Our approach represents a straightforward way to ‘add-on’ a
haplotyping option to an existing genotyping method, such as the
widely-used TaqMan-based allele differentiation. Haplotype
data can add power to genetic mapping studies, and our method
would allow researchers or clinical geneticists to utilize this
additional information even when samples from family members
are not available. We project that ultimately genome-wide
haplotype data might be routinely used to map complex traits. In
the interim, the availability of a haplotyping option for targeted
locicouldhelp to evaluatethescientific advantages of gaining this
additional layer of information. Haplotypes act like individual
highly informative markers harboring a series of rare alleles. The
additional power gained might be critical, e.g., when mapping
rare functional variation where common, less informative
markers might fail to show maximum association, or in
pharmacogenomic studies, where sample sizes are small and
replication samples are unattainable [23]. In our own studies,
genetic admixture potentially leads to allelic heterogeneity.
Labeling and mapping European and African chromosomes
separately in our patients might help to overcome this difficulty
and make full use of the enhanced resolution [16] of African-
derived chromosomes for finemapping. Additional genetic and
epigenetic information, such as copy number variation (CNV
[24]) or methylation imprints, might also be tied into the SNP
haplotypes.
Table 2. Summary of haplotyping results in the patients.
allele combination tested Experiments
Targets per
probe
% co-localization
in phase
% co-localization
in repulsion haplotype combinations derived
rs9399137-T–rs9402685-T n=14 38 to 66 76% to 98% none ‘T-T/C-C’: n=14; ‘T-C/C-T’: none
rs9399137-T–rs9402685-C n=14 37 to 69 none 0% to 11% ‘T-T/C-C’: n=14; ‘T-C/C-T’: none
rs9402685-T–rs11759553-T n=13 25 to 69 84% to 100%, n=3 3% to 12%, n=10 ‘T-A/C-T’: n=10; ‘T-T/C-A’: n=3
rs9402685-C–rs11759553-T n=13 27 to 58 53% to 87%, n=10 2% to 6%, n=3 ‘T-A/C-T’: n=10; ‘T-T/C-A’: n=3
doi:10.1371/journal.pone.0013004.t002
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indicates that unequivocal phasing seems straightforward using
nanofluidic arrays. Scenarios are conceivable though that would
cause ambiguity: cross-contaminated, severely degraded, or over-
concentrated DNA samples, as well as a too wide spacing of the
SNP pair tested. For instance, the tendency of some samples to
yield co-localization scores at the lower end of the in-phase cluster,
such as FM2 (Table 1, Figure 5) might be due to partial strand
breakage in a more degraded sample. Quality control measures
implemented with our approach could include the monitoring of
score clustering and the use of control samples, i.e. phase-known
individuals or sample mixes with phase-known components. While
we have used specifically formulated primer/probe mixes, the
utilization of off-the-shelf TaqMan oligonucleotide mixes might
also be possible, provided that suitable analysis algorithms can be
devised.
The accidental inclusion of homozygous SNPs can lead to the
detection of only one of the two expected alleles, alerting to
possible genotyping errors or sample swaps.
Experimentally-derivedhaplotypes werefound, as expected,to
be not always identical to the most likely haplotype, as
mathematically inferred fromS N Pg e n o t y p e s .W h e r et h e
mathematical algorithm leaves ambiguity (in our study, ,90%
haplotype probability), it is impossible to determine in which
individuals the less probable haplotypes occur. These ‘atypical’
haplotypes would therefore be lost for functional and fine-
mapping experiments. Assigning haplotypes correctly is an
important aspect of our studies investigating sickle cell disease,
as it would be in any undertaking comparing the haplotypes
present in individuals with their phenotype or other functional
data. Thus, beyond mapping studies, experimental haplotyping
would be useful in experiments where exact allelic phase between
polymorphisms has to be know, such as in studies of cis-
regulatory effects on gene expression and other gene function
[25] or when investigating adjoining and cis-interacting func-
tional variants. A potential application in a clinical environment
is the emerging field of non-invasive prenatal diagnosis [26],
where a minor fraction of fetal DNA has to be identified against a
majority of maternal cell-free DNA in the plasma of the mother.
Here, experimental haplotyping could be used, e.g., to detect the
paternal component of a recessive condition, anchoring the
mutation originating from the father to alleles that are specific to
the affected paternal chromosome.
It is our hope that the method described here or equivalent
approaches will, in the near future, routinely add phase
information to SNP genotype data, enhancing researchers’ power
to detect, map, and ultimately understand variation in the human
genome.
Supporting Information
Methods S1 Supporting methods information.
Found at: doi:10.1371/journal.pone.0013004.s001 (0.03 MB
DOC)
Table S1 Individual digital-array haplotyping experiments of
patient samples with SNP marker pair rs9399137–rs9402685.
Found at: doi:10.1371/journal.pone.0013004.s002 (0.02 MB
XLS)
Table S2 Individual digital-array haplotyping experiments of
patient samples with SNP marker pair rs9402685–rs11759553.
For patient 48, no ‘T’ allele was detected for rs11759553. This
conflict between the digital-array result and the original genotyp-
ing result (‘A T’ heterozygous) was subsequently resolved and the
correct genotype was shown to be indeed ‘A A’ homozygous, in
agreement with the digital array data.
Found at: doi:10.1371/journal.pone.0013004.s003 (0.02 MB
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Table 3. Presence of individual HMIP-2 haplotypes in 68 patients of African and Afro-Caribbean ancestry.
Haplotype
Phase known
through
homozygosity
Inferred
mathematically
(most likely)
Determined
experimentally Discrepancy
Total present in
patients
European
population
N= N= N= N= N=(Frequency) Frequency
(1) T - T - A 52 14 11 3 63 (0.46) 0.71
(2) T - T - T 22 2 5 3 27 (0.20) 0.01
(3) T - C - A 15 0 3 3 18 (0.13) ,0.01
(4) T - C - T 13 9 6 3 19 (0.14) ,0.01
(5) C - T - A 0 0 0 0 (0.00) 0.00
(6) C - T - T 0 0 0 0 (0.00) 0.00
(7) C - C - A 0 1 1 1 (0.01) ,0.01
(8) C - C - T 2 6 6 8 (0.06) 0.27
The discrepancies between the mathematically inferred haplotypes and the experimentally detected ones arise from three individuals, where a haplotype combination
of ‘T-T-A/T-C-T’ is the most likely one, given the individual SNP genotype data, but where a combination of ‘T-T-T/T-C-A’ is actually present.
Haplotype frequencies in British Europeans, as observed in a previous study [1], are given for comparison.
doi:10.1371/journal.pone.0013004.t003
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